Intra-cellular therapies, inc. reports earnings results for the third quarter ended september 30, 2019

Intra-cellular therapies, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 36.376 million compared to usd 43.391 million a year ago. net loss was usd 34.862 million compared to usd 41.522 million a year ago. basic loss per share was usd 0.63 compared to usd 0.76 a year ago. for the nine months, operating loss was usd 112.243 million compared to usd 119.643 million a year ago. net loss was usd 107.139 million compared to usd 114.379 million a year ago. basic loss per share was usd 1.94 compared to usd 2.09 a year ago.
ITCI Ratings Summary
ITCI Quant Ranking